Superoxide Generation from eNOS: The Role of Pterins

eNOS 产生超氧化物:蝶呤的作用

基本信息

项目摘要

[] PrincipInavl estigator/PrDogireacmt(oLrasfti,rstm, iddle): DESCRIPTSIOtaNte:heapplicatiobnro'saldo,ng-teorbmjectivaensdspeciaficimsm, akinregferentoctehehealtrhelatednoefsthseprojecDt.escribe concistehleyreseardcehsigandmethofdosrachievtihnegsgeoalAs.voisdummaorifepsasatccomplishamnedtnhtesuseofthefirsptersoTnh. isabstract ismeantotservaesasuccinacnt daccuradtescriptoioftnheproposwedorwk hesneparaftreodmtheapplicatioIfnth. eapplicatiisofnundetdh,is descriptiaosni,s,willbecompeubliicnformatTiohne.refodreo,notincludperoprietary/conifnidfoernmtialtiDonO.NOTEXCEETDHESPACE PROVIDED. Tetrahydrobiopterin (BH4) is an essential cofactor of endothelial nitric oxide synthase (eNOS). Diminished NO formation and subsequent impaired relaxation have been proposed to be due to reduced endothelial BH4 levels, which enhances superoxide formation from eNOS. This idea gained support from electron paramagnetic resonance spin trapping studies showing that fully reduced BH4 inhibits superoxide release form eNOS while oxidized BH4 has no effect. In addition, these studies demonstrated that saturation of BH4- binding site is critical for inhibiting superoxide and that displacement of the cofactor from eNOS by oxidized BH4 analogs such as sepiapterin and 7,8-dihydrobiopterin elevates superoxide productionl Based on these findings we hypothesized that the ratio between fully reduced and oxidized BH4 regulates superoxide generation from endothelial nitric oxide synthase. Previous studies used L-arginine and L-arginine analogs to implicate eNOS as a source of superoxide. However, spin trapping studies showed that these compounds have little effect on superoxide release from purified eNOS. This paradox indicates that identification of eNOS as a superoxide producer remains elusive. Here, the role of eNOS in superoxide formation from BH4- depleted human coronary artery endothelial cells will be examined by pharmacological approaches using 1,14-bis-isothiourea, 7-nitroindazole or caveolin-1 sacffolding pepetide. These agents specifically inhibit oxygen activation by either impeding enzyme activation and/or blocking heme group. In addition, superoxide formation in COS-7 transfected with wild type eNOS and C99A mutant that has a low affinity off BH4 will be examined. These experiments will reveal the interplay between eNOS/BH4 in superoxide formation. In addition, it will be examined the mechanisms by which BH4 is depleted and regenerated in endothelial cells.To this end, the effect of oxidative stress on GTP cyclohydrolase-I activity and GTP feedback regulatory pep[ide will be examined. Paralle experiements will examine the role of GFRP in the regulation of BH4. Finally, it will be examined whether nitrosative/oxidative stress chnages BH4-binding to eNOS to generate an enzyme that produces superoxide by a BH4-insensitive mechanism. This information is likely to contribute in the identification of risk factors and in the design of new therapeutic interventions to ameliorate vascular function in conditions such as hypertension, atheriosclerosis and diabetes. PERFORMANCE SITE ========================================Section End===========================================
[]主要研究者/项目研究进展(中图,中图,中图):描述:研究项目的应用情况,研究项目的针对性、针对性、参与性,研究项目的研究目标和方法,研究项目的研究成果,研究项目的进展情况,研究项目的进展情况,研究项目的进展情况。它是抽象的,它是对所提出的工作在应用程序中所处位置的一个连续的数据描述。willbecompeubliicnformatTiohne.refodreo eapplicatiisofnundetdh descriptiaosni,年代,notincludperoprietary / conifnidfoernmtialtiDonO。NOTEXCEETDHESPACE提供。四氢生物蝶呤(BH4)是内皮型一氧化氮合酶(eNOS)的重要辅助因子。一氧化氮形成减少和随后的松弛受损被认为是由于内皮BH4水平降低,从而增强了eNOS的超氧化物形成。这一观点得到了电子顺磁共振自旋俘获研究的支持,研究表明完全还原的BH4抑制eNOS的超氧化物释放,而氧化的BH4则没有影响。此外,这些研究表明BH4结合位点的饱和对于抑制超氧化物至关重要,氧化BH4类似物(如七叶蝶呤和7,8-二氢生物蝶呤)从eNOS中取代辅助因子可提高超氧化物的产生。基于这些发现,我们假设完全还原和氧化BH4之间的比例调节内皮型一氧化氮合酶产生的超氧化物。先前的研究使用l -精氨酸和l -精氨酸类似物来暗示eNOS是超氧化物的来源。然而,自旋俘获研究表明,这些化合物对纯化的eNOS的超氧化物释放几乎没有影响。这一悖论表明,eNOS作为超氧化物生产者的鉴定仍然难以捉摸。在这里,eNOS在BH4缺失的人冠状动脉内皮细胞形成超氧化物中的作用将通过使用1,14-双异硫脲、7-硝基吲哚唑或caveolin-1支架肽的药理学方法进行研究。这些药物通过阻碍酶的激活和/或阻断血红素群特异性地抑制氧的激活。此外,将检测转染野生型eNOS和与BH4亲和力较低的C99A突变体的COS-7中超氧化物的形成。这些实验将揭示eNOS/BH4在超氧化物形成中的相互作用。此外,还将研究BH4在内皮细胞中耗尽和再生的机制。为此,我们将研究氧化应激对GTP环水解酶- i活性和GTP反馈调控pep的影响。平行实验将检验GFRP在BH4调控中的作用。最后,我们将研究亚硝化/氧化应激是否会改变bh4与eNOS的结合,从而产生一种通过bh4不敏感机制产生超氧化物的酶。这些信息可能有助于识别危险因素和设计新的治疗干预措施,以改善高血压、动脉粥样硬化和糖尿病等疾病的血管功能。网站性能 ======================================== 节结束 ===========================================

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEANNETTE M. VASQUEZ VIVAR其他文献

JEANNETTE M. VASQUEZ VIVAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEANNETTE M. VASQUEZ VIVAR', 18)}}的其他基金

Tetrahydrobiopterin in Hypoxia-Ischemia Induced Fetal Brain Dysfunction
四氢生物蝶呤在缺氧缺血引起的胎儿脑功能障碍中的作用
  • 批准号:
    7383759
  • 财政年份:
    2007
  • 资助金额:
    $ 18.75万
  • 项目类别:
Tetrahydrobiopterin in Hypoxia-Ischemia Induced Fetal Brain Dysfunction
四氢生物蝶呤在缺氧缺血引起的胎儿脑功能障碍中的作用
  • 批准号:
    7234659
  • 财政年份:
    2007
  • 资助金额:
    $ 18.75万
  • 项目类别:
Superoxide Generation from eNOS: The Role of Pterins
eNOS 产生超氧化物:蝶呤的作用
  • 批准号:
    6690736
  • 财政年份:
    2002
  • 资助金额:
    $ 18.75万
  • 项目类别:
Superoxide Generation from eNOS: The Role of Pterins
eNOS 产生超氧化物:蝶呤的作用
  • 批准号:
    6576413
  • 财政年份:
    2002
  • 资助金额:
    $ 18.75万
  • 项目类别:
Superoxide Generation from eNOS: The Role of Pterins
eNOS 产生超氧化物:蝶呤的作用
  • 批准号:
    7894501
  • 财政年份:
    2002
  • 资助金额:
    $ 18.75万
  • 项目类别:
Superoxide Generation from eNOS: The Role of Pterins
eNOS 产生超氧化物:蝶呤的作用
  • 批准号:
    7658765
  • 财政年份:
    2002
  • 资助金额:
    $ 18.75万
  • 项目类别:
Superoxide Generation from eNOS: The Role of Pterins
eNOS 产生超氧化物:蝶呤的作用
  • 批准号:
    6969913
  • 财政年份:
    2002
  • 资助金额:
    $ 18.75万
  • 项目类别:
Superoxide Generation from eNOS: The Role of Pterins
eNOS 产生超氧化物:蝶呤的作用
  • 批准号:
    7499544
  • 财政年份:
    2002
  • 资助金额:
    $ 18.75万
  • 项目类别:
Superoxide Generation from eNOS: The Role of Pterins
eNOS 产生超氧化物:蝶呤的作用
  • 批准号:
    7210062
  • 财政年份:
    2001
  • 资助金额:
    $ 18.75万
  • 项目类别:
DEPENDENCE OF SUPEROXIDE REACTIVITY ON YNO FLUX: AN EPR SPIN TRAPPING STUDY
超氧化物反应性对 YNO 通量的依赖性:EPR 自旋捕获研究
  • 批准号:
    6250036
  • 财政年份:
    1997
  • 资助金额:
    $ 18.75万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了